Fr. 106.00

Pituitary Disorders, An Issue of Endocrinology and Metabolism Clinics of North America

English · Hardback

Shipping usually within 3 to 5 weeks

Description

Read more

This issue of Endocrinology and Metabolism Clinics, edited by Drs. Anat Ben-Shlomo and Maria Fleseriu, is devoted to Pituitary Disorders. Articles in this issue include: Pathogenesis of Pituitary Tumors; Prognostic Clinicopathological Classification of Pituitary Adenomas; Familial Isolated Pituitary Adenomas (FIPA) and Mutations in the Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene; Pitfalls of IGF1 and GH Assays; Acromegaly: Pharmacotherapy; Hypothalamo-pituitary-adrenal Axis Testing; Pharmacotherapy of Cushing Disease: New Targets; Prolactinomas; Non-functioning Pituitary Tumors; Cabergoline Use for Pituitary Tumors and Valvular Disorders; Aggressive Atypical Pituitary Tumors and Carcinoma; Outcomes of Endoscopic Transsphenoidal Pituitary Surgery; Efficacy and Complications of Pituitary Irradiation; Hypopituitarism: GH and ACTH Deficiency; Hypophysitis; Hypopituitarism After Traumatic Brain Injury; Quality of Life in Pituitary Diseases; Pituitary and Bone Disease; Pituitary Tumor Management in Pregnancy; and Pituitary Apoplexy.

Product details

Authors Anat Ben-Shlomo, Anat (Associate Professor Ben-Shlomo, Ben-Shlomo Anat
Publisher Elsevier Health Science
 
Languages English
Product format Hardback
Released 11.03.2015
 
EAN 9780323356541
ISBN 978-0-323-35654-1
Dimensions 152 mm x 228 mm x 229 mm
Weight 520 g
Series The Clinics: Internal Medicine
Subjects Natural sciences, medicine, IT, technology > Medicine > Clinical medicine

Endocrinology, MEDICAL / Endocrinology & Metabolism

Customer reviews

No reviews have been written for this item yet. Write the first review and be helpful to other users when they decide on a purchase.

Write a review

Thumbs up or thumbs down? Write your own review.

For messages to CeDe.ch please use the contact form.

The input fields marked * are obligatory

By submitting this form you agree to our data privacy statement.